Domestic formulation sales increased by 13.8 per cent to Rs 4,300.4 crore Y-o-Y, representing 32 per cent of the company's ...
US health chiefs issued a warning about RSV jabs, which were only launched in Britain last year.In the UK, the condition is ...
Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
President Donald Trump has nominated Kennedy to be the secretary of the U.S. Department of Health and Human Services, which ...
Plus, NBC News spoke to trans service members about their thoughts on President Trump's executive order banning trans people from enlisting and serving in the military.
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults.
With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...
(CNN) – The U.S. Food and Drug Administration approved the first new type of pain medication in more than two decades, and it’s not an opioid. The drug is suzetrigine under the brand name Journavx. It ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term ...